Stimulation of the atypical chemokine receptor 3 (ACKR3) by a small-molecule agonist attenuates fibrosis in a preclinical liver but not lung injury model
小分子激动剂刺激非典型趋化因子受体 3 (ACKR3) 可减轻临床前肝脏而非肺损伤模型中的纤维化
期刊:Cellular and Molecular Life Sciences
影响因子:6.2
doi:10.1007/s00018-022-04317-y
Tom Van Loy, Steven De Jonghe, Karolien Castermans, Wouter Dheedene, Reinout Stoop, Lars Verschuren, Matthias Versele, Patrick Chaltin, Aernout Luttun, Dominique Schols
